logo-lakshmshree
Posted on  November 24, 2020 under  by Team Lakshmishree

Stock Market Today - NIFTY On Its High

Crude spikes to $ 46/bbl

Crude Oil

Crude prices are higher and you nudge around 13,000 probably there will be some volatility where crude spikes to $ 46 / bbl.

The money is still changing

Yesterday, it was a big buy, FII inflows for November almost $ 7 bn now.
FII bought Rs. 4,738 crore in the crash market yesterday.

Dollar strengthens slightly developed Mkts Vs EM trade. We can see a big rally in the Dow Jones & Dow Futures,

Dow futures are up today.

The EM market is also doing well but perhaps not as well as the Developed market.

Nifty hits Benchmark of 13,000

Nifty 50

The whole bank Nifty vs IT RIL trade is of the first sign in reversal, the way delivery selling was seen in ICICI, HDFC, etc were amusing.

On the other hand 1000 crores of delivery buying in RIL, 600 crores of delivery buying in Infosys, so that trade is making a bit of a comeback.

The overall texture is bought on dips perhaps for the next term you better focus on Nifty instead of Bank Nifty.

The Nifty is facing some congestion at 13,000 whereas Bank Nifty is facing some congestion at 30,000.

Midcaps

Midcaps index up 12.5% this month, still the go-to place.

The rally helps in the theme you have to identify the individual stocks and put money there.

Midcaps have 12.5% this month which has still got a lot of room in terms of Valuation, That's the big place to begin.

Covid-19 cures In Share Market

Covid-19

Pharma has made a big comeback led by Divi’s lab.

Pharma & diagnostic could be back in focus by Divis’s lab with testing which may impact health care.

AstraZeneca's biggest positive for the Indian market is the third vaccine now. The one that India at least was betting on the AstraZeneca vaccine.
It has shown 70% efficacy in the first dose and 90% efficacy on the two doses, and the Serum Institute is already in agreement to manufacture the vaccine in the global vaccine.

Click On The Image To Watch Pre-Market Analysis

Written by Team Lakshmishree

open-account-ad-2

Social Share

Subscribe to Our Newsletter

Loading
CIN No U74110MH2005PLC157942     |    Member Ship Details     |    BSE-3281     |    NSE-12817     |    MCX-55910     |    DP:IN-DP-CDSL-490-2008     |    DPID:12059100    |    SEBI Regn. No.: INZ000170330     |    Mutual Fund: ARN-77739    |    Research Analyst: registration number INH000014395
logo-lakshmshree-white
Lakshmishree Investment & Securities Ltd. was incorporated in 2005. We are a Corporate Member of NSE, BSE, MCX and Depository Participant with CDSL.
Most Popular in LISL
Copyright @ 2024 © Lakshmishree Investment & Securities Ltd. All Right Reserved.
Maruti Suzuki Q2 FY2025 Results: A Challenging Quarter Maharatna Companies: Driving India’s Growth! IndusInd Bank Q2FY25 Results: Profit Drop, NPA Rise, and a 20% Stock Slide Master the Markets: Best Technical Analysis Books Muhurat Trading 2024: Maximize Prosperity with Smart Investments! Key Q2 Results for Nifty 50 Companies This Week (21st October - 26th October 2024) Waaree Energies IPO 2024: India’s Solar Leader Going Public Infosys Share Price Dips 5%: Q2 Results Miss Expectations, Guidance Disappoints